These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 32972832)

  • 1. Fibrinolysis Shutdown in COVID-19-Infected Patients Can Result from Iron-Induced Stabilization of Fibril Clots.
    Sukhomlin T
    J Am Coll Surg; 2020 Nov; 231(5):607-608. PubMed ID: 32972832
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.
    Creel-Bulos C; Sniecinski R
    Shock; 2021 Jun; 55(6):845-846. PubMed ID: 33989265
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery.
    Walsh MM; Khan R; Kwaan HC; Neal MD
    J Am Coll Surg; 2021 Jun; 232(6):1003-1006. PubMed ID: 33839011
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel simultaneous clot-fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders.
    Nogami K; Matsumoto T; Sasai K; Ogiwara K; Arai N; Shima M
    Br J Haematol; 2019 Nov; 187(4):518-529. PubMed ID: 31335970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic Shutdown in COVID-19 Is Likely a Misnomer.
    Lisman T
    Shock; 2021 Jun; 55(6):844-845. PubMed ID: 33989264
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
    Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
    Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
    Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
    Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin clot formation and fibrinolysis in patients with a history of coronary stent thrombosis.
    Godschalk TC; Konings J; Govers-Riemslag JW; Ten Berg JM; Hackeng CM; Ten Cate H
    Thromb Res; 2016 Jul; 143():58-62. PubMed ID: 27191854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and biophysical conditions for blood clot lysis.
    Šabovič M; Blinc A
    Pflugers Arch; 2000 Jan; 440(Suppl 1):R134-R136. PubMed ID: 28008511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis Shutdown in Severely Injured Trauma Patients: A New World to Explore.
    Tonglet ML; D'Orio V; Ghuysen A; Poplavsky JL
    J Am Coll Surg; 2017 Dec; 225(6):831-832. PubMed ID: 29173339
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent Fibrinolysis Shutdown: In reply to Tonglet and colleagues.
    Meizoso JP; Proctor KG
    J Am Coll Surg; 2017 Dec; 225(6):832-833. PubMed ID: 29173340
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception.
    Piróg M; Piwowarczyk S; Undas A
    Dis Markers; 2019; 2019():4923535. PubMed ID: 31827635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombotic alterations in plasma fibrin clot properties in thyroid disorders and their post-treatment modifications.
    Mazur P; Sokołowski G; Hubalewska-Dydejczyk A; Płaczkiewicz-Jankowska E; Undas A
    Thromb Res; 2014 Aug; 134(2):510-7. PubMed ID: 24962680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P; Zabczyk M; Undas A
    PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
    Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?
    Nielsen ND; Rollins-Raval MA; Raval JS; Thachil J
    Thromb Res; 2022 Feb; 210():1-3. PubMed ID: 34953317
    [No Abstract]   [Full Text] [Related]  

  • 19. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
    Morishima Y; Honda Y
    J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.